公司資料
T2 Biosystems 股價、新聞與催化劑
- 股票代碼:
- TTOO
- 交易所:
- NASDAQ
- 產業:
- MedTech
- 所在地:
- United States
股票表現
0.00 USD (-50.00%)
收盤價
最後更新: 2026年8月17日
—
市值
股價為何變動
As of Aug 17, 2026, TTOO closed down 50.0% at $0.0005. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
T2 Biosystems is a medical diagnostics company focused on rapid pathogen detection and bloodstream infection testing. Its business is centered on delivering fast diagnostic information to clinical settings.
所在地與產業分類
T2 Biosystems is headquartered in the United States and listed on NASDAQ. It sits in medical diagnostics rather than biotechnology therapeutics.
商業模式特徵
The company depends on test adoption, hospital utilization, and commercialization execution in a challenging diagnostics market. Investors usually watch sales, reimbursement, and operating discipline.
生技產業定位
T2 Biosystems belongs to the diagnostics infrastructure layer of healthcare. It is not a drug developer, but it matters to clinical workflow because rapid testing can change treatment decisions.
未來催化劑
- T2 Biosystems is a legacy / closeout story now, with catalysts limited to any strategic or asset-resolution update. There is no active standalone growth story left.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。